AVF Highlights: Guidelines, Registries, Awards and Research
New Multisociety Guidelines and Evidence Base
Upcoming SVS, AVF and AVLS varicose vein guidelines rest on a 45 trial meta-analysis confirming ultrasound as the diagnostic gold standard, better short term outcomes combining saphenous ablation with phlebectomy, and no clear advantage of thermal over nonthermal ablation.
Jury Trial and Registry Infrastructure Growth
The Jury multicenter trial studying whether junctional reflux affects symptom severity has exceeded its enrollment target despite launching during the pandemic, while VQI venous registries have grown to nearly 50,000 varicose vein and 17,000 filter procedures, with a new stent registry growing.
Caprini Score and Mandatory VTE Risk Scoring
Joe Caprini described an AVF collaboration to update his VTE risk score with new risk factors and artificial intelligence, citing a Boston University program that made scoring mandatory and cut clot rates 84 percent, sustained over ten years, as a model for adoption.
Research Grants and Journal Update
Poster, Jobst and Boston Scientific grant winners presented work on standardized VTE outcome measures, bioimpedance as a chronic venous disease biomarker, and small animal models of venous stent thrombosis, alongside an update on the JVS-Venous and Lymphatic Disorders journal’s reach.
